These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21781236)

  • 21. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
    Van Damme A; Chuah MK; Collen D; VandenDriessche T
    Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver gene therapy with intein-mediated F8 trans-splicing corrects mouse haemophilia A.
    Esposito F; Lyubenova H; Tornabene P; Auricchio S; Iuliano A; Nusco E; Merlin S; Olgasi C; Manni G; Gargaro M; Fallarino F; Follenzi A; Auricchio A
    EMBO Mol Med; 2022 Jun; 14(6):e15199. PubMed ID: 35491676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
    Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
    Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of gene therapy for hemophilia: current states and future perspectives].
    Ohmori T
    Rinsho Ketsueki; 2018; 59(10):2238-2246. PubMed ID: 30305531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical and clinical gene therapy for haemophilia.
    Chuah MK; Collen D; Vandendriessche T
    Haemophilia; 2004 Oct; 10 Suppl 4():119-25. PubMed ID: 15479384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated review.
    Ay C; Frenzel L; Pinachyan K; Le Quellec S
    Haemophilia; 2024 Jan; 30(1):5-15. PubMed ID: 38111029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AAV-mediated gene transfer for hemophilia.
    High K
    Genet Med; 2002; 4(6 Suppl):56S-61S. PubMed ID: 12544490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular and genetic therapies for haemophilia.
    Lillicrap D; VandenDriessche T; High K
    Haemophilia; 2006 Jul; 12 Suppl 3():36-41. PubMed ID: 16683995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemophilia Gene Therapy: Ready for Prime Time?
    VandenDriessche T; Chuah MK
    Hum Gene Ther; 2017 Nov; 28(11):1013-1023. PubMed ID: 28793786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes.
    Andrews JL; Weaver L; Kaleko M; Connelly S
    Haemophilia; 1999 May; 5(3):160-8. PubMed ID: 10444282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia?
    Liras A
    Thromb Res; 2011 Jul; 128(1):8-13. PubMed ID: 21396685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New approaches to gene and cell therapy for hemophilia.
    Ohmori T; Mizukami H; Ozawa K; Sakata Y; Nishimura S
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S133-42. PubMed ID: 26149014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for haemophilia.
    Sharma A; Easow Mathew M; Sriganesh V; Neely JA; Kalipatnapu S
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010822. PubMed ID: 25394678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors.
    Chuah MK; Schiedner G; Thorrez L; Brown B; Johnston M; Gillijns V; Hertel S; Van Rooijen N; Lillicrap D; Collen D; VandenDriessche T; Kochanek S
    Blood; 2003 Mar; 101(5):1734-43. PubMed ID: 12406898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolving landscape of gene therapy for congenital haemophilia: An unprecedented, problematic but promising opportunity for worldwide clinical studies.
    Spadarella G; Di Minno A; Brunetti-Pierri N; Mahlangu J; Di Minno G
    Blood Rev; 2021 Mar; 46():100737. PubMed ID: 32739122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette.
    Lu H; Chen L; Wang J; Huack B; Sarkar R; Zhou S; Xu R; Ding Q; Wang X; Wang H; Xiao W
    Hum Gene Ther; 2008 Jun; 19(6):648-54. PubMed ID: 18500941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemophilia, state of the art and new therapeutic opportunities, a regulatory perspective.
    Tomeo F; Mariz S; Brunetta AL; Stoyanova-Beninska V; Penttila K; Magrelli A
    Br J Clin Pharmacol; 2021 Nov; 87(11):4183-4196. PubMed ID: 33772837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospects for gene therapy of haemophilia A and B.
    Brownlee GG
    Br Med Bull; 1995 Jan; 51(1):91-105. PubMed ID: 7767651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII.
    Scallan CD; Liu T; Parker AE; Patarroyo-White SL; Chen H; Jiang H; Vargas J; Nagy D; Powell SK; Wright JF; Sarkar R; Kazazian HH; McClelland A; Couto LB
    Blood; 2003 Dec; 102(12):3919-26. PubMed ID: 12893764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy for haemophilia.
    Sharma A; Easow Mathew M; Sriganesh V; Reiss UM
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010822. PubMed ID: 27996087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.